385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous AND/OR transdermal dosage form	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Cutaneous AND/OR transdermal dosage form	Is a	Dose form by site prepared for	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Nystatin + triamcinolone acetonide 100000unt/1mg cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nystatin + triamcinolone acetonide 100000unt/1mg ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nystatin + triamcinolone acetonide 10000unt/1mg ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Norelgestromin+ethinyl estradiol 6mg/0.75mg patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Pimecrolimus 1% cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing amphotericin in topical dosage form	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cleocin t 10mg/ml lotion	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Salicylic acid gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing clonidine in transdermal dose form (medicinal product form)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing tacrolimus in topical dosage form	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing betamethasone and calcipotriol	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Methyl aminolevulinate 168mg/g topical cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing lidocaine and tetracaine	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 70mg/tetracaine 70mg transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely metronidazole 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely dapsone 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely griseofulvin 10 milligram/1 milliliter conventional release cutaneous spray (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous spray (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing ichthammol and zinc oxide	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing benzoyl peroxide and clindamycin	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing calamine and dibrompropamidine	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing desoximetasone and salicylic acid	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing methyl nicotinate	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing diethylamine salicylate	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing 9 cis-octadecenoic acid and turpentine oil (medicinal product)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Selegiline 6mg/24hours transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Selegiline 9mg/24hours transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Selegiline 12mg/24hours transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Pyrethrin 0.33%/4% piperonyl butoxide topical aerosol mousse	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ciclopirox 10 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely lidocaine 70 milligram/1 gram and tetracaine 70 milligram/1 gram conventional release cutaneous cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ketoconazole 20 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous foam (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 2.5% topical ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diphenhydramine 2%/zinc acetate 0.1% topical cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely desonide 500 microgram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing testosterone in topical dosage form	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Catechin 15% topical ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing clindamycin and tretinoin	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clindamycin 1.2%/tretinoin 0.025% topical gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Iodine 0.7%/isopropyl alcohol 74% w/w topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing terbinafine in topical dosage form	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing capsaicin	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar 30% bath emulsion	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lignocaine 5% / Hydrocortisone acetate 0.275% ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Norethisterone 170micrograms/24hours / Estradiol 50micrograms/24hours patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely lactic acid 40 milligram/1 gram and salicylic acid 120 milligram/1 gram conventional release cutaneous gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% + Pramocaine 1% foam enema	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 1.25g/dose gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Testosterone 15mg transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Salicylic acid 20% 7.5cmx4.5cm plaster	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Salicylic acid 40% 7.5cmx4.5cm plaster	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Enbucrilate 500mg tissue adhesive	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous ointment	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Gamolenic acid 20% cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Biological active component 2mL vial/thrombin sealant solution 2mL vial	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Evening primrose oil 20% cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely triamcinolone acetonide 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely dithranol 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely polynoxylin 100 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Biological active component 5mL vial/thrombin sealant solution 5mL vial	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing polynoxylin	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Biological active component 1mL vial/thrombin sealant solution 1mL vial	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing glycol salicylate and methyl nicotinate	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diclofenac epolamine 1.3% transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rotigotine 4mg/24hours transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rotigotine 2mg/24hours transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 0.25mg/dose topical gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rotigotine 6mg/24hours transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Avobenzone 2%/ecamsule 3%/octocrilene 10% topical cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Miscellaneous topical minor anti-infective	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Avobenzone 2%/ecamsule 2%/octocrilene 10% topical cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing acetic acid and turpentine oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rivastigmine 4.6mg/24 hours transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing terebene	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rivastigmine 9.5mg/24 hours transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely adapalene 3 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing tar oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 1.53mg transdermal spray	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing turpentine oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing rectified birch tar oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing rectified pine tar oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Human thrombin topical solution 5mL vial	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Human thrombin topical solution 20mL vial	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing alkali-metal soap and camphor and turpentine oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing alpha-pinene	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous foam (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Human thrombin topical solution 2mL vial	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing pinene	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Pinene hydrochloride	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing camphene	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Bovine thrombin 5000iu powder for topical solution + 5mL vial diluent	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Bovine thrombin 20000iu powder for topical solution + 20mL vial diluent	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier

Start Previous Page 10 of 55 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT core module